Ipca share price today: ₹1,926.20 at the close on Thursday, 29 October 2026, down ₹4.30 (−0.22%) from the previous close of ₹1,930.50. Ipca Laboratories (NSE: IPCALAB) traded between ₹1,910.50 and ₹1,978.00 that day, on 1.91 lakh shares.
Ipca support and resistance: the nearest support is ₹1,921.40 and the nearest resistance ₹1,976.50 on the 15-minute chart. Ipca 52-week high and low: ₹2,038.00 and ₹1,268.00; it closed 5.5% below that high and 51.9% above that low.
The chart above is live while NSE trades (9:15 am to 3:30 pm IST, Monday to Friday): candles from 1 minute to daily, 10 years of daily history and 140+ indicators and studies, free to open with no account.
At the close on Thursday, 29 October 2026
Prices from NSE. The chart above streams them live while the market is open.
The near levels: the ones the chart's Auto Support & Resistance overlay draws on Ipca's 15-minute chart, nearest first, below and above the price at the close, ₹1,926.20. They come from the last 30 days of 15-minute candles (30 Sept to 29 Oct). A level is a price where the share's swings turned before; the more turns, the more established it is. Each level is the middle of the narrow band where its swings turned, so it can sit slightly above or below a day's exact high or low.
Nearest: ₹1,921.40 (2 turns, the latest at 3:15 pm on 26 Oct)
Next: ₹1,909.25 (2 turns, the latest at 9:15 am on 29 Oct)
Nearest: ₹1,976.50 (2 turns, the latest at 10:00 am on 29 Oct)
Next: ₹1,984.90 (1 turn, the latest at 9:45 am on 5 Oct)
Levels describe where the price reacted before. They are not a forecast or a recommendation, and the price can move straight through them. On the chart above, pick 15m and switch on Overlays → Auto Support & Resistance (free with an account) to see them drawn; on any other timeframe it draws that timeframe's own levels.
How far Ipca's price at the close (₹1,926.20) is from its close a week, a month, 3 months and 6 months earlier, and from its 52-week high and low. Price change only: dividends are not added back.
High ₹2,038.00, on 22 Sept 2026: the price closed 5.5% below it.
Low ₹1,268.00, on 31 Oct 2025: the price closed 51.9% above it.
Prices stream as Ipca trades on NSE, from 9:15 am to 3:30 pm IST, and the newest candle forms as you watch. Outside market hours the chart shows the last session, ending at its close.
Candles from 1 minute to daily — 1, 3, 5, 10, 15 and 30 minutes, 1 to 4 hours, and daily — with 10 years of daily history to scroll back through, as candles, bars, line or Heikin Ashi.
140+ indicators and studies (moving averages, RSI, MACD, Bollinger Bands, VWAP, Supertrend, volume profile and more), drawing tools and symbol compare. Opening the chart needs no account; a second indicator, the overlays such as Auto Support & Resistance, price alerts and Alpha AI need a free account.
Price, open, high, low, previous close and volume: NSE, at the 29 Oct close.
52-week high and low: NSE's own figures.
Market cap, PE and price to book: Ipca's filed results (consolidated) at the price above, the same figures as Ipca's financials page.
Support and resistance: Alphave's Auto Support & Resistance on 15-minute candles, 30 Sept to 29 Oct.
Delivery and the 20-day average volume: NSE's daily delivery and volume data.
Price history: closing prices from Alphave's daily NSE candles.
Alphave is run by its founder, Amit Meena. If a figure here looks wrong, email [email protected] and it will be checked and corrected.
Ipca Laboratories is a pharmaceutical company manufacturing branded and generic formulations and active pharmaceutical ingredients (APIs). Its domestic branded business is strong in pain management (Zerodol franchise), rheumatology, anti-malarials and cardiovascular therapies; it is a leading global producer of APIs such as hydroxychloroquine and artemisinin-based anti-malarials. It acquired control of Unichem Laboratories to expand US generics exposure. Revenue is driven by India branded formulations, export formulations and APIs.
It is a top-20 Indian pharma company by domestic sales with global leadership in select APIs like hydroxychloroquine.
Ipca share price today: ₹1,926.20 at the close on Thursday, 29 October 2026, down ₹4.30 (−0.22%) from the previous close of ₹1,930.50. Ipca Laboratories (NSE: IPCALAB) traded between ₹1,910.50 and ₹1,978.00 that day, on 1.91 lakh shares. NSE trades again from 9:15 am IST on the next trading day.
On the 15-minute chart (the last 30 days of 15-minute candles, to 29 Oct), against the price of ₹1,926.20 at the close, Ipca has support at ₹1,921.40 (2 turns, the latest at 3:15 pm on 26 Oct) and ₹1,909.25 (2 turns, the latest at 9:15 am on 29 Oct), and resistance at ₹1,976.50 (2 turns, the latest at 10:00 am on 29 Oct) and ₹1,984.90 (1 turn, the latest at 9:45 am on 5 Oct). These are prices where the share turned before, not a forecast. The chart's Auto Support & Resistance overlay draws them, and every other timeframe's own levels.
At the top of this page. The Ipca (NSE: IPCALAB) chart is live while NSE trades, from 9:15 am to 3:30 pm IST, with candles from 1 minute to daily, 10 years of daily history and 140+ indicators, and it opens free with no account.
Ipca's 52-week high is ₹2,038.00 (22 Sept 2026) and its 52-week low ₹1,268.00 (31 Oct 2025). At the 29 Oct close of ₹1,926.20, it is 5.5% below the high and 51.9% above the low.
Ipca's market capitalisation is ₹48,868 crore at the 29 Oct close (25.37 crore shares at ₹1,926.20 each), and its PE ratio 37.3 on consolidated net profit attributable to shareholders over the last four quarters (Q2 FY26 to Q1 FY27), or 42.8 on FY26 profit; its price to book is 6.06. Its next results are due on 5 November 2026, and the PE will change with them. The figures behind them are on Ipca's financials page.
At the 29 Oct close (₹1,926.20), Ipca is +1.19% over 1 week, −0.61% over 1 month, +8.55% over 3 months and +24.91% over 6 months, on price alone. The chart above has 10 years of daily history.
IPCALAB (ISIN INE571A01038). It is part of the Nifty Midcap 150, Nifty 500, Nifty Healthcare and Nifty Pharma. Sector: Pharma & Health, Pharma.
No. This page and the chart show market data for information only. They are not a recommendation to buy or sell any security.
Prices from NSE, at the 29 Oct close. Market data for information only, not a recommendation to buy or sell.